These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 31707122)
21. [Long-term prognostic analysis on complete/near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy]. Wang L; Li S; Zhang X; Sun T; Du C; Chen N; Peng Y; Yao Y; Zhan T; Zhao J; Cai Y; Li Y; Wang W; Li Z; Sun Y; Ji J; Wu A Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1240-1248. PubMed ID: 30506534 [TBL] [Abstract][Full Text] [Related]
22. Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report. Madbouly KM; Hussein AM World J Surg; 2015 May; 39(5):1248-56. PubMed ID: 25561197 [TBL] [Abstract][Full Text] [Related]
23. A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer. Jung M; Shin SJ; Koom WS; Jung I; Keum KC; Hur H; Min BS; Baik SH; Kim NK; Kim H; Lim JS; Hong SP; Kim TI; Roh JK; Park YS; Ahn JB Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1015-22. PubMed ID: 26581140 [TBL] [Abstract][Full Text] [Related]
24. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer. Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M J BUON; 2013; 18(2):385-90. PubMed ID: 23818350 [TBL] [Abstract][Full Text] [Related]
25. Long-term results of a randomized trial in locally advanced rectal cancer: no benefit from adding a brachytherapy boost. Appelt AL; Vogelius IR; Pløen J; Rafaelsen SR; Lindebjerg J; Havelund BM; Bentzen SM; Jakobsen A Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):110-8. PubMed ID: 25015203 [TBL] [Abstract][Full Text] [Related]
26. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L; Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473 [TBL] [Abstract][Full Text] [Related]
27. Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration. Spiegel DY; Boyer MJ; Hong JC; Williams CD; Kelley MJ; Moore H; Salama JK; Palta M Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):565-573. PubMed ID: 30359718 [TBL] [Abstract][Full Text] [Related]
28. High-dose radiotherapy (60 Gy) with oral UFT/folinic acid and escalating doses of oxaliplatin in patients with non-resectable locally advanced rectal cancer (LARC): a phase I trial. Vestermark LW; Jensen HA; Pfeiffer P Acta Oncol; 2012 Mar; 51(3):311-7. PubMed ID: 22248062 [TBL] [Abstract][Full Text] [Related]
29. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526 [TBL] [Abstract][Full Text] [Related]
30. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients. Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515 [TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life in rectal cancer patients undergoing neoadjuvant chemoradiation with delayed surgery versus short-course radiotherapy with immediate surgery: a propensity score-matched cohort study. Couwenberg AM; Burbach JPM; Intven MPW; Consten ECJ; Schiphorst AHW; Smits AB; Wijffels NAT; Heikens JT; Koopman M; van Grevenstein WMU; Verkooijen HM Acta Oncol; 2019 Apr; 58(4):407-416. PubMed ID: 30656996 [TBL] [Abstract][Full Text] [Related]
32. Intentional Watch and Wait or Organ Preservation Surgery Following Neoadjuvant Chemoradiotherapy Plus Consolidation CAPEOX for MRI-defined Low-risk Rectal Cancer: Findings From a Prospective Phase 2 Trial (PKUCH-R01 Trial, NCT02860234). Wang L; Zhang XY; Zhao YM; Li SJ; Li ZW; Sun YS; Wang WH; Wu AW; Ann Surg; 2023 Apr; 277(4):647-654. PubMed ID: 35766394 [TBL] [Abstract][Full Text] [Related]
33. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Cai G; Zhu J; Palmer JD; Xu Y; Hu W; Gu W; Cai S; Zhang Z Radiat Oncol; 2015 Feb; 10():57. PubMed ID: 25889149 [TBL] [Abstract][Full Text] [Related]
34. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE). Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356 [TBL] [Abstract][Full Text] [Related]
35. [Total neoadjuvant therapy followed by watch and wait approach or organ preservation for MRI stratified low-risk rectal cancer: early result from a prospective, single arm trial]. Wang L; Zhao YM; Sun TT; Xu YL; Li SJ; Zhang XY; Cai Y; Li YH; Li ZW; Chen PJ; Peng YF; Wang WH; Wu AW Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):258-265. PubMed ID: 32192305 [No Abstract] [Full Text] [Related]
36. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks? Perez RO; Habr-Gama A; São Julião GP; Gama-Rodrigues J; Sousa AH; Campos FG; Imperiale AR; Lynn PB; Proscurshim I; Nahas SC; Ono CR; Buchpiguel CA Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1159-65. PubMed ID: 22580120 [TBL] [Abstract][Full Text] [Related]
37. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979 [TBL] [Abstract][Full Text] [Related]
38. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968 [TBL] [Abstract][Full Text] [Related]
39. Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: long-term results from a single-center experience. Mazzola R; Ferrera G; Cucchiara T; Figlia V; Gueci M; Sciumè F; Di Paola G; Scibetta N; Lo Casto A; Pappalardo MP; Lagalla R; Alongi F Tumori; 2016 Jun; 2016(3):316-22. PubMed ID: 27002948 [TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial. Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T; Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]